Functional divergence of Kaposi's sarcoma-associated herpesvirus and related gamma-2 herpesvirus thymidine kinases: Novel cytoplasmic phosphoproteins that alter cellular morphology and disrupt adhesion

Journal of Virology

Volumn 79, Issue 23, 2005, Pages 14647-14659

  Gill, Michael B ^a,b   Murphy, Jo Ellen ^c   Fingeroth, Joyce D ^a,b,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; GREEN FLUORESCENT PROTEIN; HOLOENZYME; HYBRID PROTEIN; PHOSPHOPROTEIN; THYMIDINE KINASE;

AMINO TERMINAL SEQUENCE; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL NUCLEUS; CELL SHAPE; CELL STRUCTURE; CELL SURFACE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; HERPES SIMPLEX VIRUS 1; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; INTERMEDIATE FILAMENT; KAPOSI SARCOMA; MICROFILAMENT; MICROTUBULE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RHADINOVIRUS;

CELL ADHESION; CELL CULTURE TECHNIQUES; HERPESVIRUS 8, HUMAN; HUMANS; PHOSPHOPROTEINS; RHADINOVIRUS; SARCOMA, KAPOSI; THYMIDINE KINASE;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA ASSOCIATED HERPESVIRUS; MACACA MULATTA; RHADINOVIRUS; SAIMIRIINE HERPESVIRUS 2;

EID: 27744520838     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.23.14647-14659.2005     Document Type: Article

References (50)

1. Bechtel, J. T., R. C. Winant, and D. Ganem. 2005. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79:4952-4964.
2. Bouamr, F., J. A. Melillo, M. Q. Wang, K. Nagashima, M. de Los Santos, A. Rein, and S. P. Goff. 2003. PPPYVPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101. J. Virol. 77:11882-11895. (Author's correction, 78:4383, 2004.)
3. Brinkmann, M. M., M. Glenn, L. Rainbow, A. Kieser, C. Henke-Gendo, and T. F. Schulz. 2003. Activation of mitogen-activated protein kinase and NF-κB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J. Virol. 77:9346-9358.
4. Bull, T. M., C. D. Cool, A. E. Serls, P. R. Rai, J. Parr, J. M. Neid, M. W. Geraci, T. B. Campbell, N. F. Voelkel, and D. B. Badesch. 2003. Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8. Eur. Respir. J. 22:403-407.
5. Caron, E. 2003. Cellular functions of the Rap1 GTP-binding protein: a pattern emerges. J. Cell Sci. 116:435-440.
6. Cesarman. E. 2003. Kaposi's sarcoma-associated herpesvirus-the high cost of viral survival. N. Engl. J. Med. 349:1107-1109.
7. Coen, D. M., M. Kosz-Vnenchak, J. G. Jacobson, D. A. Leib, C. L. Bogard, P. A. Schaffer, K. L. Tyler, and D. M. Knipe. 1989. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA 86:4736-4740.
8. Coleman, H. M., B. de Lima, V. Morton, and P. G. Stevenson. 2003. Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency. J. Virol. 77:2410-2417.
9. Corpet, F. 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16:10881-10890.
10. Crumpacker, C. S., II. 1989. Molecular targets of antiviral therapy. N. Engl. J. Med. 321:163-172.
11. Danen, E. H., and A. Sonnenberg. 2003. Integrins in regulation of tissue development and function. J. Pathol. 200:471-480.
12. Degreve, B., M. Johansson, E. De Clercq, A. Karlsson, and J. Balzarini. 1998. Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK. J. Virol. 72:9535-9543.
13. Efstathiou, S., S. Kemp, G. Darby, and A. C. Minson. 1989. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 70:869-879.
14. Engels, E. A., R. J. Biggar, V. A. Marshall, M. A. Walters, C. J. Gamache, D. Whitby, and J. J. Goedert. 2003. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS 17:1847-1851.
15. Gaspar, G., E. De Clercq, and J. Neyts. 2002. Gammaherpesviruses encode functional dihydrofolate reductase activity. Biochem. Biophys. Res. Commun. 297:756-759.
16. Gentry, G. A. 1992. Viral thymidine kinases and their relatives. Pharmacol. Ther. 54:319-355.
17. Geuijen, C. A., and A. Sonnenberg. 2002. Dynamics of the α6β4 integrin in keratinocytes. Mol. Biol. Cell 13:3845-3858.
18. Gill, M. B., J. Roecklein-Canfield, D. R. Sage, M. Zambela-Soediono, N. Longtine, M. Uknis, and J. D. Fingeroth. 2004. EBV attachment stimulates FHOS/FHOD1 redistribution and co-aggregation with CD21: formin interactions with the cytoplasmic domain of human CD21. J. Cell Sci. 117:2709-2720.
19. Goodwin, E. C., E. Yang, C. J. Lee, H. W. Lee, D. DiMaio, and E. S. Hwang. 2000. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 97:10978-10983.
20. Gustafson, E. A., A. C. Chillemi, D. R. Sage, and J. D. Fingeroth. 1998. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase. Antimicrob. Agents Chemother. 42:2923-2931.
21. Gustafson, E. A., R. F. Schinazi, and J. D. Fingeroth. 2000. Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir. J. Virol. 74:684-692.
22. Holt, M. R., and A. Koffer. 2001. Cell motility: proline-rich proteins promote protrusions. Trends Cell Biol. 11:38-46.
23. Holton, R. H., and G. A. Gentry. 1996. The Epstein-Barr virus genome encodes deoxythymidine kinase activity in a nested internal open reading frame. Intervirology 39:270-274.
24. Irish, J. M., R. Hovland, P. O. Krutzik, O. D. Ferez, O. Bruserud, B. T. Gjertsen, and G. P. Nolan. 2004. Single cell profiling of potentiated phosphoprotein networks in cancer cells. Cell 118:217-228.
25. Isnardi, I., R. Lesourne, P. Bruhns, W. H. Fridman, J. C. Cambier, and M. Daeron. 2004. Two distinct tyrosine-based motifs enable the inhibitory receptor FcγRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap. J. Biol. Chem. 279:51931-51938.
26. Kay, B. K., M. P. Williamson, and M. Sudol. 2000. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14:231-241.
27. Kim, H., T. G. Peterson, and S. Barnes. 1998. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am. J. Clin. Nutr. 68(Suppl. 6):1418S-1425S.
28. Kim, S. Y., N. Chudapongse, S. M. Lee, M. C. Levin, J. T. Oh, H. J. Park, and I. K. Ho. 2005. Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res. Mol. Brain Res. 133:58-70.
29. Lee, R. K., J. P. Cai, V. Deyev, P. S. Gill, L. Cabral, C. Wood, R. P. Agarwal, W. Xia, L. H. Boise, E. Podack, and W. J. Harrington, Jr. 1999. Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. Cancer Res. 59:5514-5520.
30. Lock, M. J., N. Thorley, J. Teo, and V. C. Emery. 2002. Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase. J. Antimicrob. Chemother. 49:359-366.
31. Longhurst, C. M., and L. K. Jennings. 1998. Integrin-mediated signal transduction. Cell. Mol. Life Sci. 54:514-526.
32. McGeoch, D. J., and A. J. Davison. 1999. The descent of human herpesvirus 8. Semin. Cancer Biol. 9:201-209.
33. Mentzer, S. J., J. Fingeroth, J. J. Reilly, S. P. Perrine, and D. V. Faller. 1998. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma. Blood Cells Mol. Dis. 24:114-123.
34. Moore, P. S., and Y. Chang. 2001. Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:499-516.
35. Ogino, S., K. Tsuruma, T. Uehara, and Y. Nomura. 2004. Herbimycin A abrogates nuclear factor-κB activation by interacting preferentially with the IκB kinase beta subunit. Mol. Pharmacol. 65:1344-1351.
36. Oldak, M., H. Smola, M. Aumailley, F. Rivero, H. Pfister, and S. Smola-Hess. 2004. The human papillomavirus type 8 E2 protein suppresses β4-integrin expression in primary human keratinocytes. J. Virol. 78:10738-10746.
37. Patcha, V., J. Wigren, M. E. Winberg, B. Rasmusson, J. Li, and E. Sarndahl. 2004. Differential inside-out activation of beta2-integrins by leukotriene B4 and fMLP in human neutrophils. Exp. Cell Res. 300:308-319.
38. Paulose-Murphy, M., N. K. Ha, C. Xiang, Y. Chen, L. Gillim, R. Yarchoan, P. Meltzer, M. Bittner, J. Trent, and S. Zeichner. 2001. Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol. 75:4843-4853.
39. Plemenitas, A., X. Lu, M. Geyer, P. Veranic, M. N. Simon, and B. M. Peterlin. 1999. Activation of Ste20 by Nef from human immunodeficiency virus induces cytoskeletal rearrangements and downstream effector functions in Saccharomyces cerevisiae. Virology 258:271-281.
40. Roychowdhury, S., R. Peng, R. A. Baiocchi, D. Bhatt, S. Vourganti, J. Grecula, N. Gupta, C. F. Eisenbeis, G. J. Nuovo, W. Yang, P. Schmalbrock, A. Ferketich, M. Moeschberger, P. Porcu, R. F. Barth, and M. A. Caligiuri. 2003. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Res. 63:965-971.
41. Rubsam, L. Z., B. L. Davidson, and D. S. Shewach. 1998. Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D- arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killing. Cancer Res. 58:3873-3882.
42. Sakurada, S., H. Katano, T. Sata, H. Ohkuni, T. Watanabe, and S. Mori. 2001. Effective human herpesvirus 8 infection of human umbilical vein endothelial cells by cell-mediated transmission. J. Virol. 75:7717-7722.
43. Schon, M., J. Benwood, T. O'Connell-Willstaedt, and J. G. Rheinwald. 1999. Human sweat gland myoepithelial cells express a unique set of cytokeratins and reveal the potential for alternative epithelial and mesenchymal differentiation states in culture. J. Cell Sci. 112:1925-1936.
44. Sharp, T. V., H. W. Wang, A. Koumi, D. Hollyman, Y. Endo, H. Ye, M. Q. Du, and C. Boshoff. 2002. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J. Virol. 76:802-816.
45. Song, M. J., H. Deng, and R. Sun. 2003. Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 77:9451-9462.
46. Tung, P. P., and W. C. Summers. 1994. Substrate specificity of Epstein-Barr virus thymidine kinase. Antimicrob. Agents Chemother. 38:2175-2179.
47. Unwin, R. D., D. W. Sternberg, Y. Lu, A. Pierce, D. G. Gilliland, and A. D. Whetton. 2005. Global effects of BCR/ABL and TEL/PDGFRβ expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR/ABL. J. Biol. Chem. 280:6316-6326.
48. Westphal, E. M., W. Blackstock, W. Feng, B. Israel, and S. C. Kenney. 2000. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies. Cancer Res. 60:5781-5788.
49. Yasuda, J., M. Nakao, Y. Kawaoka, and H. Shida. 2003. Nedd4 regulates egress of Ebola virus-like particles from host cells. J. Virol. 77:9987-9992.
50. Yu, L., J. V. White, and T. F. Smith. 1998. A homology identification method that combines protein sequence and structure information. Protein Sci. 7:2499-2510.